Novel germline mutations in the PTEN tumour suppressor gene found in women with multiple cancers
- PMID: 10807691
- PMCID: PMC1734596
- DOI: 10.1136/jmg.37.5.336
Novel germline mutations in the PTEN tumour suppressor gene found in women with multiple cancers
Abstract
Germline mutations in PTEN can predispose people to Cowden syndrome (CS) and Bannayan-Ruvalcaba-Riley (BRR) syndrome, rare, autosomal dominantly inherited neoplastic disorders. To determine whether germline mutations in PTEN contribute to genetic predisposition to multiple primary tumours within the general population, we conducted a nested case-control study, among 32 826 members of the prospective Nurses' Health Study cohort; cases were women with more than one primary tumour at different anatomical sites. We screened all nine exons of PTEN and flanking intronic splice sites for all 103 eligible cases using SSCP and sequencing. We observed two novel germline heterozygous missense mutations in exon 5 in five of the cases; three were V119L and two were V158L. Neither mutation was observed in 115 controls free of diagnosed cancer (p = 0.02). Both mutants showed partial tumour suppressor activity when compared to wild type PTEN when transfected into a PTEN null breast cancer cell line. The phenotype was cell line specific suggesting that genetic background affects growth suppression activity of the mutants. These data provide evidence that germline mutations in PTEN may be a more frequent predisposing factor for cancers in women than previously suggested.
Similar articles
-
Germline mutations in the PTEN gene in Israeli patients with Bannayan-Riley-Ruvalcaba syndrome and women with familial breast cancer.Clin Genet. 2002 Oct;62(4):298-302. doi: 10.1034/j.1399-0004.2002.620407.x. Clin Genet. 2002. PMID: 12372056
-
PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome.Hum Mol Genet. 1999 Aug;8(8):1461-72. doi: 10.1093/hmg/8.8.1461. Hum Mol Genet. 1999. PMID: 10400993
-
Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway.Am J Hum Genet. 2003 Aug;73(2):404-11. doi: 10.1086/377109. Epub 2003 Jul 3. Am J Hum Genet. 2003. PMID: 12844284 Free PMC article.
-
Mutations of the human PTEN gene.Hum Mutat. 2000;16(2):109-22. doi: 10.1002/1098-1004(200008)16:2<109::AID-HUMU3>3.0.CO;2-0. Hum Mutat. 2000. PMID: 10923032 Review.
-
The role of PTEN, a phosphatase gene, in inherited and sporadic nonmedullary thyroid tumors.Recent Prog Horm Res. 1999;54:441-52; discussion 453. Recent Prog Horm Res. 1999. PMID: 10548886 Review.
Cited by
-
Activation of the mTOR pathway by low levels of xenoestrogens in breast epithelial cells from high-risk women.Carcinogenesis. 2011 Nov;32(11):1724-33. doi: 10.1093/carcin/bgr196. Epub 2011 Sep 1. Carcinogenesis. 2011. PMID: 21890461 Free PMC article.
-
Incidence of multiple primary cancers in a cohort of women diagnosed with breast cancer in southeast England.Br J Cancer. 2001 Feb 2;84(3):435-40. doi: 10.1054/bjoc.2000.1603. Br J Cancer. 2001. PMID: 11161413 Free PMC article.
-
Clinical management of hereditary breast cancer syndromes.J Mammary Gland Biol Neoplasia. 2011 Apr;16(1):17-25. doi: 10.1007/s10911-011-9200-x. Epub 2011 Mar 1. J Mammary Gland Biol Neoplasia. 2011. PMID: 21360002 Review.
-
The Association of PTEN Gene Mutations with the Breast Cancer Risk: A Systematic Review and Meta-analysis.Biochem Genet. 2024 Jun;62(3):1617-1635. doi: 10.1007/s10528-023-10464-z. Epub 2023 Sep 2. Biochem Genet. 2024. PMID: 37658255
-
Cowden syndrome: a critical review of the clinical literature.J Genet Couns. 2009 Feb;18(1):13-27. doi: 10.1007/s10897-008-9187-7. Epub 2008 Oct 30. J Genet Couns. 2009. PMID: 18972196 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials